vancomycin has been researched along with Coronary Restenosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angsantikul, P; Carpenter, C; Chen, TC; Chien, S; Dehaini, D; Fang, RH; Gao, W; Hofman, FM; Hu, CM; Kroll, AV; Luk, BT; Nguyen, P; Patel, SH; Qu, V; Ramesh, M; Shi, W; Thamphiwatana, S; Wang, KC; Wen, CH; Zhang, K; Zhang, L; Zhu, J | 1 |
1 other study(ies) available for vancomycin and Coronary Restenosis
Article | Year |
---|---|
Nanoparticle biointerfacing by platelet membrane cloaking.
Topics: Animals; Anti-Bacterial Agents; Blood Platelets; Blood Vessels; Cell Membrane; Collagen; Complement Activation; Coronary Restenosis; Disease Models, Animal; Docetaxel; Drug Delivery Systems; Humans; Macrophages; Male; Mice; Nanoparticles; Platelet Adhesiveness; Polymers; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Taxoids; Unilamellar Liposomes; Vancomycin | 2015 |